Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D's IDDP Program funds for-profit research to advance innovative type 1 diabetes therapies and technologies toward commercial application.
Funder: Breakthrough T1D
Due Dates: Rolling (inquiries accepted year-round)
Funding Amounts: No fixed maximum; typical awards vary by project scope and negotiated terms.
Summary: Supports for-profit organizations conducting research in alignment with Breakthrough T1D’s priority areas to advance type 1 diabetes therapies with commercial potential.
Key Information: Indirect costs are not permitted; company matching funds and royalty payback terms may apply.
Description
The Industry Discovery & Development Partnership (IDDP) Program is a funding mechanism from Breakthrough T1D designed specifically for for-profit organizations. The program aims to accelerate the translation of innovative research and product development in type 1 diabetes (T1D) by leveraging the expertise and commercial capabilities of industry partners. Projects must closely align with Breakthrough T1D’s research priorities and demonstrate clear potential for advancing new treatments, therapeutics, or technologies for T1D. The program encourages collaborations that can bridge the gap between early-stage research and commercial application, with the ultimate goal of delivering new solutions to people living with T1D.
